Everolimus R-CHOP combination safe for treating diffuse large B-cell lymphoma

(Mayo Clinic) The targeted therapy everolimus may be safely combined with R-CHOP for new, untreated diffuse large B-cell lymphoma according to the results of a pilot study by Mayo Clinic researchers published in the Lancet Haematology. R-CHOP is a combination of drugs used to treat lymphoma. The combination includes rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news